Cite
HARVARD Citation
De La Chapa, J. et al. (2019). The novel capsazepine analog, CIDD‐99, significantly inhibits oral squamous cell carcinoma in vivo through a TRPV1‐independent induction of ER stress, mitochondrial dysfunction, and apoptosis. Journal of oral pathology & medicine. pp. 389-399. [Online].